National Institutes of Health Director Jay Bhattacharya launched a new bi-monthly “Scientific Freedom Lecture” series with a ...

Four years after infection with the wild-type SARS-CoV-2 strain, up to 60% of health care workers (HCWs) in Switzerland still ...

The group’s core expertise lies in translational research on emerging viruses with direct real-world impact, including the acceleration of diagnostic solutions, the provision of evidence for public ...

The use of the nucleic acid platform for antigen delivery has expanded rapidly in the past decade, highlighted by the development and deployment of several nucleic acid vaccines for SARS-CoV-2 and the ...

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for ...

A study published Wednesday shows that the early U.S. death toll during the COVID-19 pandemic was higher than previously recorded. The journal Science Advances found that more than 155,000 ...

The question of origins has long bedevilled the study of pandemics. In pre-modern times, outbreaks of infectious disease were ...

Hannah Murphy. When the University of Minnesota Crookston welcomed new faculty members to campus in August 2025, Hannah Murphy, assistant professor in biology, arrived ready to cr ...

Receiving the COVID-19 vaccine and booster reduces preeclampsia risk by nearly 60% among pregnant patients with preexisting morbidities.

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.